Compare · CHPT vs SNN
CHPT vs SNN
Side-by-side comparison of ChargePoint Holdings Inc. (CHPT) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- CHPT operates in Consumer Discretionary, while SNN operates in Health Care - the two are in different parts of the market.
- SNN is the larger of the two at $12.89B, about 69.0x CHPT ($186.7M).
- Over the past year, CHPT is down 54.0% and SNN is up 1.6% - SNN leads by 55.6 points.
- CHPT has been more active in the news (15 items in the past 4 weeks vs 12 for SNN).
- CHPT has more recent analyst coverage (25 ratings vs 23 for SNN).
- Company
- ChargePoint Holdings Inc.
- Smith & Nephew SNATS Inc.
- Price
- $7.21-0.35%
- $30.35-0.85%
- Market cap
- $186.7M
- $12.89B
- 1M return
- +17.03%
- +0.96%
- 1Y return
- -53.96%
- +1.61%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 15
- 12
- Recent ratings
- 25
- 23
ChargePoint Holdings Inc.
ChargePoint Holdings, Inc. provides electric vehicle (EV) charging networks and charging solutions in the United States. It offers a portfolio of hardware, software, and services for commercial, fleet, and residential customers. The company was founded in 2007 and is headquartered in Campbell, California.
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest CHPT
- SEC Form 10-Q filed by ChargePoint Holdings Inc.
- ChargePoint Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- ChargePoint Reports First Quarter Fiscal Year 2027 Financial Results
- General Counsel Batill Eric was granted 70,000 shares, increasing direct ownership by 89% to 148,610 units (SEC Form 4)
- CFO Khetani Mansi was granted 59,000 shares, increasing direct ownership by 46% to 187,500 units (SEC Form 4)
- CRO Vice John David was granted 54,000 shares, increasing direct ownership by 44% to 175,579 units (SEC Form 4)
- CAO Novruzova Natella Fakhradovna was granted 20,000 shares, increasing direct ownership by 173% to 31,557 units (SEC Form 4)
- CCXO Singh Jagdeep Ca was granted 75,000 shares, increasing direct ownership by 61% to 197,565 units (SEC Form 4)
- ChargePoint Announces Inducement Grants Under NYSE Listed Company Manual Section 303A.08
- ChargePoint and Powers Parts Partner Simplify Fast Charging for Transit Operators
Latest SNN
- Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith & Nephew downgraded by Kepler
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- A Reno Biotech Just Rang the Nasdaq Bell — Here's Why the Whole Regenerative-Medicine Tape Is Worth Watching
- SEC Form SD filed by Smith & Nephew SNATS Inc.